Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSEA Effects on Postpartum Pelvic Floor Function
NCT02334150Phase 3Completed
- Sponsor
- Nanjing Maternal and Child Health Hospital
- Start
- Jun 2013
- Primary completion
- Jun 2014
- Modality
- Targeted Liposomes, Orthosteric Ligands, Stealth (PEGylated) Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine hydrochloride liposomal suspension injection, sufentanil in labor pain, sponsored by Nanjing Maternal and Child Health Hospital. Started Jun 2013; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injectionsufentanil
03
Conditions
labor pain
Beyond the preview
Go deeper on NCT02334150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02334150.